2023 annual financial data
Ovid Therapeutics 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -11,678.81%.
Operating income was -59,281,000 USD and net income was -52,339,000 USD.
Operating cash flow was -45,780,925 USD.
Get free Ovid Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 392,000 USD
- Operating income
- -59,281,000 USD
- Net income
- -52,339,000 USD
- Operating cash flow
- -45,780,925 USD